Evidence map›Paper›PMID 37638287›Full record

ArticleInternational journal of hematology-oncology and stem cell research2023

Prognostic Value of the Expression of Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic Leukemia.

Aysun Şentürk Yikilmaz, Şule Mine Bakanay, Duygu Nurdan Avcı, Sema Akinci, Mesude Falay, Gülsüm Özet, İmdat Dilek

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of hematology-oncology and stem cell research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Aysun Şentürk YikilmazDepartment of Hematology, Bilkent City Hospital, Yıldırım Beyazıt University, Ankara, Turkey.
Şule Mine BakanayDepartment of Hematology, Bilkent City Hospital, Yıldırım Beyazıt University, Ankara, Turkey.
Duygu Nurdan AvcıDepartment of Hematology, Ankara Numune Training and Research Hospital, Ankara, Turkey.
Sema AkinciDepartment of Hematology, Atatürk Training and Research Hospital, Ankara, Turkey.
Mesude FalayDepartment of Hematology, Ankara Numune Training and Research Hospital, Ankara, Turkey.
Gülsüm ÖzetDepartment of Hematology, Ankara Numune Training and Research Hospital, Ankara, Turkey.
İmdat DilekDepartment of Hematology, Bilkent City Hospital, Yıldırım Beyazıt University, Ankara, Turkey.
Ankara Numune Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chronic lymphocytic leukemia (CLL)The transmembrane receptor tyrosine kinase-like orphan receptor 1 (ROR1)

Identifiers

PMID37638287
PMCPMC10448922
OpenAlexW4317036493

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.